^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    COMPANY:
    StageZero Life Sci

    i
    Other names: StageZero Life Sciences. Ltd. | StageZero Life Sciences. Ltd | StageZero Life Sciences Ltd. | StageZero Life Sciences Ltd | StageZero Life Sciences, Inc. | StageZero Life Sciences, Inc | StageZero Life Sciences Inc. | StageZero Life Sciences Inc | StageZero Life Sciences, Ltd. | Care Oncology, Inc. | Care Oncology, Inc | Care Oncology Inc. | Care Oncology Inc
    Related tests:
    Evidence

    News

    6ms
    StageZero Life Sciences and ElevationMD Introduce Aristotle and AVRT for the Early Detection of Cancer (StageZero Life Sci Press Release)
    "StageZero Life Sciences...and ElevationMD ( “ElevationMD”) today announced the introduction of Aristotle and AVRT for the early detection of cancer as well as screening for metabolic markers for identifying and managing the early warning signs of chronic disease for the prevention of cancer."
    Clinical
    |
    Aristotle®
    almost3years
    Results from METRICs study informs expansion of StageZero’s new Care Oncology Protocol (StageZero Life Sci Press Release)
    "StageZero Life Sciences, Ltd...announced significant enhancements to the company's proprietary Care Oncology Protocol ('COC Protocol')...Launch of New Protocol will now make the connection between patients' metabolic health and cancer outcomes using advanced biomarker testing and interactive digital health platform to actively track patient progress."
    Launch
    over3years
    StageZero Life Sciences partners with DiagnoseAtHome to offer Aristotle(R) multi-cancer blood test in Canada and USA (StageZero Life Sci Press Release)
    "StageZero Life Sciences, Ltd...announced that it has partnered with DiagnoseAtHome...to make the Company's multi-cancer blood test, Aristotle®, available to DiagnoseAtHome's patients in Canada and the USA. Built on StageZero's proprietary mRNA gene expression technology platform, Aristotle is a next-generation test which simultaneously screens for multiple cancers from a single sample of blood."
    Licensing / partnership
    |
    Aristotle®